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Abstract
Introduction: Hepatobiliary elimination of endo- and xenobiotics is affected by different variables including
hepatic perfusion, hepatocellular energy state and functional integrity of transporter proteins, all of which are
altered during sepsis. A particular impairment of hepatocellular transport at the canalicular pole resulting in an
accumulation of potentially hepatotoxic compounds would have major implications for critical care pharmacology
and diagnostics.
Methods: Hepatic transcellular transport, that is, uptake and hepatobiliary excretion, was studied in a rodent model
of severe polymicrobial sepsis by two different biophotonic techniques to obtain insights into the handling of
potentially toxic endo- and xenobiotics in sepsis. Direct and indirect in vivo imaging of the liver was performed by
intravital multifluorescence microscopy and non-invasive whole-body near-infrared (NIRF) imaging after
administration of two different, primarily hepatobiliary excreted xenobiotics, the organic anionic dyes indocyanine
green (ICG) and DY635. Subsequent quantitative data analysis enabled assessment of hepatic uptake and fate of
these model substrates under conditions of sepsis.
Results: Fifteen hours after sepsis induction, animals displayed clinical and laboratory signs of multiple organ
dysfunction, including moderate liver injury, cholestasis and an impairment of sinusoidal perfusion. With respect to
hepatocellular transport of both dyes, excretion into bile was significantly delayed for both dyes and resulted in
net accumulation of potentially cytotoxic xenobiotics in the liver parenchyma (for example, specific dye
fluorescence in liver at 30 minutes in sham versus sepsis: ICG: 75% versus 89%; DY635 20% versus 40% of
maximum fluorescence; P < 0.05). Transcutaneous assessment of ICG fluorescence by whole body NIRF imaging
revealed a significant increase of ICG fluorescence from the 30th minute on in the bowel region of the abdomen
in sham but not in septic animals, confirming a sepsis-associated failure of canalicular excretion.
Conclusions: Hepatocytes accumulate organic anions under conditions of sepsis-associated organ dysfunction.
These results have potential implications for monitoring liver function, critical care pharmacology and the
understanding of drug-induced liver injury in the critically ill.
Introduction
Sepsis reflects a systemic inflammatory syndrome in
response to an infection and represents the leading
cause of death in the intensive care unit [1]. A hallmark
of this disease is (multiple) organ dysfunction, including
liver dysfunction, ultimately determining the outcome of
sepsis.
In critically ill patients, liver dysfunction can vary from
subclinical injury to overt failure. An ever growing body
of evidence supports the concept that among the differ-
ent functions of the liver primarily the hepatic excretory
function, that is, the elimination of endo- and xenobio-
tics, is impaired during the course of sepsis resulting in
cholestasis [2-6]. Sepsis-associated liver dysfunction is
traditionally viewed as a late feature of critical illness
indicated by jaundice and hyperbilirubinemia. However,
recent studies have revealed liver dysfunction as an early
event in sepsis [4,7].
* Correspondence: Andreas.Kortgen@med.uni-jena.de
1Integrated Research and Treatment Center - Center for Sepsis Control and
Care, Jena University Hospital, Erlanger Allee 101, 07747 Jena, Germany
Full list of author information is available at the end of the article
Gonnert et al. Critical Care 2013, 17:R67
http://ccforum.com/content/17/2/R67
© 2013 Gonnert et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Hepatic excretory function is mediated by various fac-
tors including hepatic perfusion, binding to plasma pro-
teins, hepatocellular energy state, uptake across the
basolateral membrane, intracellular binding to proteins
with subsequent transcellular transport, metabolism and
canalicular excretion into bile [8]. In sepsis, each indivi-
dual step is likely to be influenced by cytokines and
other inflammatory mediators [9].
Of note, recent reports hint at a differential suscept-
ibility of the two polar surfaces of hepatocytes with the
canalicular pole being more sensitive to endotoxin and
cytokines [3,4,7,10]. Maximal basolateral uptake rate
exceeds canalicular efflux due to a much larger surface
area on the sinusoidal side of the cell. Given the particu-
lar susceptibility of canalicular transporters to endotoxin
and cytokines, impaired biliary excretion may lead to
intracellular accumulation of potentially hepatotoxic
compounds in sepsis [11] (Figure 1). This is particularly
pertinent for critically ill patients due to the large
amount of drugs they receive.
Biophotonics, that is, the development and application
of light-based technologies, particularly imaging techni-
ques, to study biological processes is a rapidly evolving
scientific field in the life sciences and medicine. We
have previously reported a technique for investigation of
hepatobiliary excretory function in the rat by intravital
multifluorescence microscopy enabling an assessment of
not only uptake, but also transcellular transport and bili-
ary excretion of two different model substrates [12].
This approach was established with indocyanine green
(ICG), a well characterized, near-infrared FDA-approved
fluorescent dye that is widely used in medical diagnos-
tics including quantitative liver function testing. To opti-
mize visualization, the hemicyanine dye DY635 was
validated for assessing hepatic excretory function.
In the present study, we applied this technique in a
fluid-resuscitated rat model of polymicrobial sepsis. In
addition, we report a non-invasive biophotonic approach
capable of specifically monitoring the canalicular pole by
whole body near-infrared fluorescence (NIRF) imaging.
These approaches allowed us to analyse sepsis-asso-
ciated impairment of hepatic excretory function, demon-
strating potential implications for the clinical setting.
Materials and methods
Animals
Male Wistar rats (12 to 16 weeks old, body weight 400
± 50 g; Harlan Laboratories, Horst, Netherlands) were
used in this study. All animal procedures were approved
by the regional animal welfare committee (Thuringian
Figure 1 Simplified illustration of sepsis-associated impairment of hepatobiliary excretion. Endo- and xenobiotics are taken up from the
bloodstream via transport proteins at the basolateral pole. After transcellular transport with or without biotransformation, endo- and xenobiotics
are biliary excreted via transport proteins at the canalicular pole. Sufficient hepatic excretory function depends on various factors which all can
be impaired under septic conditions. Atorvastatin can serve as a typical example for profoundly impaired pharmacokinetics under septic
conditions leading to supratherapeutic plasma levels after a single oral dose [23]. E, endobiotics; X, xenobiotics).
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State Office for Food Safety and Consumer Protection,
Department for Animal Welfare, Bad Langensalza,
Thuringia, Germany). Body temperature was maintained
at 37°C during all experimental procedures. All surgical
preparations were performed under aseptic conditions.
Animals were instrumented after application of local
anesthetics under desflurane anesthesia (Baxter, Munich,
Germany).
Sepsis model
A reliable and reproducible sepsis model reflecting many
features of human sepsis was applied [13,14]. In brief,
this model relies on polymicrobial peritoneal infection
induced by intraperitoneal injection of a standardized,
microbiologically characterized stool suspension result-
ing in severe peritoneal and systemic inflammation with
consecutive multiple organ dysfunction and finally death
of all animals after approximately two days if no antibio-
tics are administered. Fifteen hours post insult the
expected mortality varies between 15% and 30%.
Animals were randomly allocated to the sham or sep-
tic group (septic group, 1.75 ml/kg stool suspension,
diluted (1:4) in saline; sham group, a similar volume of
saline). Both groups received fluid resuscitation with a
balanced salt solution (10 ml/kg/hour, Jonosteril®, Fre-
senius Kabi, Bad Homburg, Germany) via an internal
jugular venous catheter inserted and tunnelled subcuta-
neously to the nape of the neck 24 hours before induc-
tion of sepsis.
Clinical characterization of septic animals
To assess the severity of sepsis at the time point of
investigation (15 hours post infection), the clinical status
was evaluated as described in detail previously [14]. In
addition, the volume of peritoneal fluid (ml) and fibrin
film generation (scoring 0 to 3) were determined before
surgical preparation for intravital microscopy. For whole
blood analyses and plasma collection, heparin or ethyle-
nediaminetetraacetic acid (EDTA) was used as the antic-
oagulant as warranted for the particular test. Blood
samples were analyzed immediately after collection
using an automated veterinary hematology analyzer
(PocH-100iV Diff; Sysmex, Leipzig, Germany). For
plasma collection, blood was centrifuged at 4,700 × g
and 4°C for 10 minutes and the plasma immediately
snap-frozen in liquid nitrogen and stored at -80°C for
further analyses. Laboratory markers of organ dysfunc-
tion were analyzed using an automated clinical chemis-
try analyzer (Fuji Dri-Chem 3500i; Sysmex). IL-6
cytokine levels were determined using Rat-Quantikine
enzyme-linked immunosorbent assay kits (R and D Sys-
tems, Wiesbaden, Germany) according to the manufac-
turer’s instructions.
Dyes for analysis of hepatocellular transport
Due to their exclusively hepatobiliary clearance as well
as their fluorescent properties [12,15] ICG (Pulsion
Medical Systems SE, Feldkirchen, Germany) and the
benzopyrylium-based hemocyanine dye DY635 (Dyomics
GmbH, Jena, Germany) were applied for assessment of
hepatocellular transport by intravital microscopy. ICG
was chosen due to its known pharmacokinetics [15] and
its established use in the clinical setting [16]. ICG hand-
ling by the liver is predicted from its plasma disappear-
ance curve and represents a widely used method for
liver function testing. DY635 is also primarily hepatobili-
ary excreted and, therefore, suitable for analysis of hepa-
tocellular transport with the advantage of better
visualization of hepatobiliary transport due to its physi-
cochemical properties [12]. However, it is not suitable
for indirect visualization of hepatobiliary excretory func-
tion by transcutaneous whole body NIRF imaging due
to the shorter wavelength of its fluorescence emission
spectrum with concomitant lower tissue penetration.
Dyes were administered via the jugular vein catheter
and studied at equimolar dosages (14 pmol/g body
weight) which have been identified as optimal concen-
trations for intravital microscopy in preliminary studies
(data not shown).
Assessment of hepatocellular transport by direct
detection of both dyes in bile
Fifteen hours post insult, animals were anesthetized and
a laparotomy for cannulation of the choledochal duct
with a polyethylene catheter was performed. For inter-
mittent analysis of the dye concentration (n = 12 per
dye, that is, n = 6 sham and n = 6 sepsis) in blood and
bile after administration, samples were drawn at baseline
and at 15 and 30 minutes. To assess dye concentrations
a standard curve was generated in the respective fluid
(plasma or bile) without the presence of the dye using a
fluorophotometer (BMG Labtech GmbH, Offenburg,
Germany). In addition, cumulative bile flow was calcu-
lated by weighing the collected bile.
Assessment of hepatocellular transport by intravital
fluorescence microscopy of the liver
In additional experiments, sinusoidal delivery and biliary
clearance of both dyes (n = 8 per dye, that is, n = 4
sham and n = 4 sepsis) were visualized by using an
inverted epifluorescence microscope (AxioObserver® Z1;
Zeiss, Jena, Germany) as described in detail previously
[12]. In brief, 15 hours post insult, animals were
anesthetized and a laparotomy was performed in order
to exteriorize one liver lobule. Using an x40/0.6 objec-
tive lens, the liver surface was epi-illuminated with a
100-watt mercury lamp with two filter sets: 365- to 395-
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nm excitation and 445- to 450-nm emission band pass
filters (4’,6-diamidino-2-phenylindole (DAPI) filterset)
were applied for visualization of the liver architecture
(autofluorescence resulting from hepatocellular reduced
pyridine nucleotides (NADH)). Depending on the
injected dye, 775- to 805-nm excitation and 845- to
855-nm emission band pass filters (ICG) or 630- to 660-
nm excitation and 650- to 690-nm emission band pass
filters (DY635) were used.
Eight pericentral and eight periportal regions of each
animal were assessed. Optimal gain, exposure time and
enhancement settings were defined in preliminary stu-
dies. After acquisition of baseline images, the dye was
administered and images were captured every five min-
utes over a 30-minute period. Fluorescence intensities of
both dyes were quantified densitometrically and are
expressed as the relative decrease of specific fluores-
cence intensity (%).
For evaluation of the hepatic microcirculation, five 20-
second video sequences per animal were recorded with
the x20 objective lens and the DAPI filterset. Sinusoidal
perfusion failure was determined by evaluating the pre-
dominant flow classified as absent, sluggish, normal or
brisk in sinusoids crossing a 100 μm circle by two inde-
pendent investigators blinded to the experimental group.
Assessment of hepatocellular transport by non-invasive
near-infrared whole-body fluorescence (NIRF) imaging
Due to superior fluorescent properties for NIRF ima-
ging, ICG alone could be used for transcutaneous
assessment of hepatocellular transport. The whole-body
NIRF imaging device (Maestro™, Cri, Woburn, MA,
USA) was equipped with a 710- to 760-nm excitation
band pass and an 800 nm emission long pass filter.
Animals (n = 5 sham and n = 5 sepsis) were fed with
a specific manganese-reduced diet over a four-week per-
iod prior to commencing the experiments (to avoid
interference by the near-infrared properties of manga-
nese). These animals were treated and instrumented
prior to experiments as described above. In addition, the
abdominal region of all animals was shaved prior to the
experiment. Fifteen hours post insult, ICG was adminis-
tered intravenously (14 pmol/g body weight). Fluores-
cence emission was recorded before and at 2, 4, 6, 8, 10,
30, 90, 150 and 300 minutes after injection of ICG with
the whole-body NIRF imaging system under short
anesthesia. Subsequently, a laparotomy was performed
and images were taken of the exposed abdominal cavity.
Fluorescence intensities at the upper right quadrant of
the abdomen (liver) and at both lower quadrants of the
abdomen (bowel) were semi quantitatively determined
in manually selected circular regions of interest (ROIs)
drafted with the same standard. Analysis was performed
by an investigator blinded to the experimental groups.
Fluorescence intensities are indicated as scaled counts/
second, reflecting count levels after scaling for the
effects of exposure time, binning and camera gain.
Statistics
All data were examined for normal distribution (Kolmo-
gorow-Smirnov test) and subsequent tests were applied
as appropriate. Differences between groups were ana-
lysed by t-test or chi square test, as appropriate. For
analysis of time-dependent changes within groups, the
Friedman test was applied. Data are presented as mean
± standard error of the mean (SEM) or percentages,
respectively. A P value < 0.05 was considered significant.
Results
Polymicrobial sepsis resulted in liver injury, severe
cholestasis and impaired microcirculation
Septic animals displayed clinical signs of disease includ-
ing a substantial decrease in activity and accumulation
of peritoneal exudate as well as laboratory signs of sys-
temic inflammation paralleled by multiple organ dys-
function (Table 1), including hepatocellular injury,
increased markers of cholestasis and a reduced cumula-
tive bile flow (Table 2).
Polymicrobial sepsis resulted in a substantial impair-
ment of sinusoidal perfusion with a profound increase
in the number of non-perfused sinusoids and a
decreased portion of normal or brisk perfused sinusoids
(Figure 2).
Table 1 Assessment of disease severity and laboratory







Activity score 1 (active) to 5
(lethargic)
1.0 ± 0.0 3.9 ± 0.2a
Peritoneal
exudate
ml 0 5.3 ± 0.5a
Fibrin generation 0 (none) to 3 (massive) 0 2.6 ± 0.2a
White cell count × 103/μl 5 ± 0.4 0.9 ± 0.1a
Platelets × 103/μl 504.4 ± 32.1 294.7 ± 53.1a
IL6 pg/ml 407 ± 88 6,013 ±
2426a
LDH IU/l 233.3 ± 25.7 695.4 ± 65.8a
Ammonia μmol/l 200.2 ± 21.4 278.4 ± 35.9
AST IU/l 76.3 ± 11.7 202.3 ± 43.5a
Albumin g/dL 2.6 ± 0.1 1.5 ± 0.1a
Hematocrit % 40.2 ± 0.6 49.4 ± 1.2a
aP < 0.05 compared to sham. AST, aspartate aminotransferase; IL6, interleukin-
6; LDH, lactate dehydrogenase; SEM, standard error of the mean. N = 12 per
group.
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Sepsis-associated impairment of hepatobiliary excretion is
reflected in low recovery rates of DY635 and ICG in bile
Peak plasma levels of both dyes one minute after admin-
istration were not different between sham and septic
animals (DY635 sham versus sepsis: 253 ± 13 versus
325 ± 38 nM, non-significant (n.s.); ICG sham versus
sepsis: 129 ± 11 versus 85 ± 12 μM, n.s.), and 15 min-
utes after administration both dyes were no longer
detectable in plasma. However, excretion of both dyes
differed. DY635 and ICG appeared more rapidly and at
higher concentrations in the bile of sham animals
(Figure 3A, 2C). Cumulative biliary recovery of both
dyes over the observation period of 30 minutes showed
a significantly higher absolute amount of substance
recovered in sham compared to septic animals (DY 635
sham versus sepsis (Figure 3B): 3,092 ± 161 versus 1,711
± 186 pmol, P ≤ 0.001; ICG sham versus sepsis (Figure
3D): 1,109 ± 167 versus 616 ± 51 pmol, P = 0.013).
Consequently, 59% and 31% (DY635) as well as 20% and
11% (ICG) of the administered amount of substance
could be recovered within 30 minutes in sham and sep-
tic animals, respectively.
DY635 and ICG are rapidly cleared from plasma with
concomitant accumulation in hepatocytes under
conditions of sepsis
Assessment of hepatocellular transport by intravital micro-
scopy revealed no differences in the uptake of DY635 from
blood between sham and septic animals (Figure 4A,
ascending part of the graph): five minutes after administra-
tion, DY635 reached maximum concentrations in the liver.
Specific fluorescence of DY635 decreased to 20 ± 3.6% in
sham and 40 ± 5.5% in septic animals within 30 minutes
(P = 0.02). ICG exhibited prolonged uptake times in septic
(peak at 15 minutes) compared to sham-operated animals
(peak at 5 minutes) (Figure 4A, ascending part of the
graph). Canalicular excretion of ICG was significantly
delayed in septic rats. The relative decrease of specific
fluorescence of ICG at 30 minutes equaled 75 ± 3.1% and
89 ± 2.6% (P = 0.011) in sham and septic rats, respectively.
The kinetics of both dyes could reliably differentiate septic
animals from sham-treated controls. Thus, biliary clear-
ance for both dyes was impaired under conditions of sep-
sis and resulted in an accumulation of both dyes in
hepatocytes (Figure 4B, Additional file 1).
Hepatocellular transport is specifically impaired at the
canalicular pole
Next, hepatocellular transport of ICG was non-invasively
evaluated by whole-body NIRF imaging over the pro-
longed observation period of five hours in sham and
septic animals. While transcutaneous assessment of ICG
fluorescence in the liver region of the abdomen failed to
reveal any differences between sham and septic rats
(Figure 5A), a significant increase of ICG fluorescence
from the 30th minute on could be detected in the bowel
region of the abdomen in sham but not in septic ani-
mals (Figure 5B), confirming a sepsis-associated failure
of canalicular excretion. In contrast to the transcuta-
neous approach, biooptical NIRF recordings in all ani-
mals with an opened abdominal situs at five hours post
administration of the dye (Figure 6A) confirmed an
accumulation of ICG in the liver (Figure 6B) and under-
lined the significantly lower ICG fluorescence in the
bowel region of the abdomen in septic animals.
Table 2 Laboratory markers of liver injury and sepsis–
associated cholestasis
sham sepsis
Unit mean ± SEM mean ± SEM
Cumulative bile flow μl·kg-1·min-1 45.0 ± 5.0 20.3 ± 3.5a
GGT IU/l 3.4 ± 0.6 13.2 ± 2.1a
ALT IU/l 32 ± 5.2 90.6 ± 16.8a
Total bilirubin μmol/l 7.1 ± 0.6 15.2 ± 1.3a
aP < 0.05 compared to sham. ALT, alanine aminotransferase; GGT, gamma-
glutamyl-transferase; SEM, standard error of the mean. N = 12 per group.
Figure 2 Effects of polymicrobial sepsis on sinusoidal
microcirculation. Sinusoidal microcirculation (n = 4 animals/group,
5 regions of interest/rat) was assessed by intravital microscopy 15
hours after induction of sepsis. Bars represent the proportion of
non-perfused sinusoids or velocity of sinusoidal prefusion,
respectively. Open bars indicate sham-operated controls; filled bars
indicate septic animals. *P < 0.05 for sham versus sepsis (’no’: P =
0.009; ‘brisk’: P = 0.02). Septic animals had an overall shift to
reduced sinusoidal perfusion.
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Figure 3 Effects of polymicrobial sepsis on biliary excretion of two xenobiotics (DY635, ICG). Kinetics of (A) DY635 and (C) ICG with
respect to biliary excretion in sham-operated as opposed to septic rats over an observation period of 30 minutes after intravenous
administration (14 pmol/g; n = 6 animals/group; 15 hours after induction of sepsis). Cumulative biliary excretion of (B) DY635 and (D) ICG,
respectively. *P < 0.05 for sham versus sepsis (DY635: P ≤ 0.001; ICG: P = 0.013). In septic animals biliary recovery of the two dyes was
significantly reduced. ICG, indocyanine green.
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Figure 4 Direct visualization of sinusoidal perfusion, hepatocellular uptake and biliary excretion of DY635 and ICG in polymicrobial
sepsis assessed by intravital fluorescence microscopy. (A) Kinetics of uptake and excretion of equimolar amounts of both dyes (14 pmol/g)
by the liver as measured by densitometric assessment of the dyes (n = 4 animals/group, 8 periportal and 8 pericentral regions of interest/rat; 15
hours after induction of sepsis). Individual grey density maxima were set to 100. Depicted data represent precentage values of individual
maximum. *P < 0.05 for sham versus sepsis. #P < 0.05 for within-group comparison. (B) Representative images (original magnification x400) of
the same field of view of a liver lobule at baseline and at 5, 15 and 30 minutes after administration of DY635 (upper panel) and ICG (lower
panel), respectively. Bar indicates 20 μm. For ICG, 775- to 805-nm excitation and 845- to 855-nm emission band pass filters and for DY635 630-
to 640-nm excitation and 650- to 690 emission band pass filters were used. Images were pseudocolored to reveal differences in pixel intensity.
Pseudocolored white-red (green-blue) regions reflect areas with high (low) grey densities. For the first image, 365- to 395-nm excitation and
445- to 450-nm emission band pass filters were applied for visualization of the liver architecture (pseudocolor blue). Black areas represent the
sinusoids whereas blue areas represent hepatocytes. Hepatocellular uptake of the dyes occurs rapidly after intravenous administration. Then dye
concentrations decrease over time reflecting hepatobiliary excretion. In comparison to sham animals, hepatobiliary excretion is impaired in
septic animals reflected by the slower decrease of fluorescence intensity. While we could not detect a different uptake of DY635 between septic
and sham animals, uptake of ICG seems to be slower as peak fluorescence in septic animals was postponed from 5 to 15 minutes. ICG,
indocyanine green.
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Figure 5 Transcutaneous whole-body near-infrared fluorescence (NIRF) imaging of ICG enables non-invasive assessment of impaired
hepatobiliary excretion in polymicrobial sepsis. Fifteen hours post induction of sepsis, ICG fluorescence was assessed transcutaneously by a
whole body NIRF imaging device over a time period of 300 minutes (semi-quantitative analysis, n = 5 animals/group) at the indicated
timepoints. *P < 0.05 for sham versus sepsis (90.min: P = 0.019; 150.min: P = 0.001; 300.min: P = 0.005). Kinetics of emitted fluorescence
intensities of ICG detected in (A) the liver region or (B) the bowel region of the abdomen. While different fluorescence intensities between sham
and septic animals could not be demonstrated in the liver region, fluorescence intensities in the bowel region significantly differed between
sham and septic animals. This hints towards a substantial impairment of biliary ICG excretion in septic animals. ICG, indocyanine green.
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Discussion
In the present study, we applied in vivo imaging in com-
bination with fluorophotometric determination of ICG
and DY635 kinetics, including uptake, intracellular
transport and excretion, enabling us to analyze the effi-
ciency of the hepatocellular transport systems under
conditions of sepsis. Visualization of the hepatobiliary
excretory function in septic animals demonstrated a
profound impairment of hepatocellular transport, speci-
fically at the canalicular pole.
Our findings of a sepsis-associated impairment of
hepatic excretory function specifically at the canalicular
pole support and strengthen recent reports about
mechanisms of a disturbance of the hepatocellular trans-
port machinery in early sepsis. As indicated above, an
efficient hepatobiliary excretion is the net result of many
functioning variables. Accordingly, the delayed dye
clearance in septic animals observed in this study may
be due to compromised distribution or altered uptake
kinetics. However, uptake of both dyes was not severely
impaired despite a significantly impaired microcircula-
tion in septic animals. Albeit slightly prolonged uptake
times could be detected for ICG, both dyes were com-
pletely cleared from plasma within 15 minutes. More-
over, no renal clearance of the potentially unbound
fraction of either DY635 or ICG (data not shown) was
observed. Therefore, the effect of a compromised micro-
circulation seems to be of limited significance under the
given conditions, albeit this might be different in ani-
mals with an even more profoundly impaired microcir-
culation, that is, in septic shock with severe hypotension
or in chronic liver disease with increased intrahepatic
vascular resistance and consecutive portal hypertension
leading to porto-systemic shunting.
Analysis of cumulative recovered bile at 30 minutes
revealed significantly lower amounts of both dyes in sep-
tic animals strongly suggesting an impaired transport at
the canalicular pole. Applying non-invasive whole-body
NIRF imaging enabled us to indirectly assess the canali-
cular pole by measuring emitted fluorescence from the
bowel region. In septic animals, the impairment of
excretion at the canalicular pole became obvious since
almost no fluorescence could be detected in this region
five hours after administration.
Intravital microscopy of the liver revealed comparable
distribution and uptake phases for both dyes in sham
and septic animals, but a markedly different hepatobili-
ary excretion of DY635 compared to ICG. Moreover,
the appearance and cumulative recovery of DY635 in
bile also differed from ICG with a more rapid appear-
ance and a quantitatively higher amount recovered in
both sham and septic animals. Whether accelerated
transmembrane transport or intracellular binding and
transport that differ from ICG are responsible for the
much faster hepatobiliary clearance of DY635 remains
speculative. Nevertheless, uptake of both dyes within 15
minutes could be confirmed as well as a profound hepa-
tic excretory dysfunction resulting in hepatic accumula-
tion of both dyes in septic as opposed to sham animals.
In contrast to DY635, the mechanisms of ICG trans-
port are well defined. ICG uptake in the rat is mediated
by a mechanism mainly involving the organic anion
transporting polypeptide-1 (Oatp1) [17,18]. After intra-
cellular binding to ligandin(s) ICG is transported to the
Figure 6 Whole-body NIRF imaging at the opened situs clearly
demonstrates an impairment specifically at the canalicular
pole under conditions of sepsis. (A) Depicted are representative
images taken 300 minutes after the experiment at the opened situs
confirming an accumulation of ICG in the liver of septic animals,
with an almost absent fluorescence signal in the bowel. The overlay
is of fluorescence (false colors: blue (low fluorescence intensity) and
red (high fluorescence intensity)) and white-light images. (B) Depicts
the detected fluorescence intensities in liver and bowel of all
animals at the open situs 300 minutes after administration of ICG. *P
< 0.05 for sham versus sepsis (’liver’: P = 0.008; ‘bowel’: P = 0.002).
Gonnert et al. Critical Care 2013, 17:R67
http://ccforum.com/content/17/2/R67
Page 9 of 12
canalicular surface of the hepatocyte and is mainly
excreted via Mdr2 [19]. Rodent Mdr2 and its human
homolog MDR3 translocate phospholipids and several
xenobiotics from the cytosolic to the luminal leaflet of
the canalicular membrane [20].
A recent study by our group revealed a differential
gene expression of basolateral and canalicular transpor-
ters for ICG and bilirubin in human precision-cut liver
slices [4]: whereas genes encoding prototypical canalicu-
lar transporters (MRP2, MDR3) were down-regulated
after cytokine stimulation and glutathione depletion,
genes encoding the basolateral transporters (OATP1,
OATP2) were maintained or even up-regulated, suggest-
ing maintained uptake of ICG from sinusoidal blood but
impaired ability to transport the bilirubin/ICG at the
canalicular pole. In addition, in a rodent model of sepsis
not only a sepsis-associated down-regulation of canali-
cular transporters, such as Mrp2 (affecting transcription,
translation and post-translational modification), but also
an association of the degree of down-regulation with
predicted outcome was demonstrated. In particular,
posttranslational changes, that is, a withdrawal of micro-
villi and related Mrp2 transporters from the canalicular
membrane, could be detected under septic conditions
[7]. The differential susceptibility of the two polar sur-
faces of hepatocytes is further supported by findings in
liver transplant recipients: in those patients with remote
organ failure and/or primary graft dysfunction, biliary
ICG excretion dropped dramatically, whereas ICG
uptake rate was far less reduced [4]. Altogether, these
findings can provide reasonable mechanistic explana-
tions for the observed impairment of hepatobiliary
excretion in this study. However, whether the impaired
canalicular ICG excretion observed results solely from
down-regulation of Mdr2 or if there is an additional
functional impairment remains uncertain. Also a dis-
turbed energy state with ATP-depletion due to the
detected perfusion disorders leading to malfunction of
ATP-dependent canalicular transporters is possible.
Measurement of the plasma disappearance rate of ICG
(PDRICG), a quantitative liver function test, renders a
complex measure of both sinusoidal perfusion as well as
basolateral hepatic (cell) membrane function. Thus, it
reflects the functional reserve of hepatocytes which have
access to perfusion. While measuring PDRICG represents
a widely used and approved method for liver function
testing in acute and chronic hepatic disorders, the test
lacks detailed information about liver-bile interactions,
thereby failing to evaluate specifically canalicular trans-
port, an increasingly recognized component of sepsis-
associated excretory dysfunction [3,4,7,10,16]. In the
present study, we have successfully applied a non-inva-
sive biophotonic technique using ICG for assessment of
the canalicular pole which could not be monitored in
the routine clinical setting up to now. Limitations
remain, which impede an immediate transfer of this
optical method into clinical practice as current NIRF
imaging systems lack an adequate anatomical resolution
and tissue penetration of fluorescence is restricted.
Although a prognostic value of PDRICG in critically ill
patients, even in the early course of the disease, has
been demonstrated [4,21,22], the test is, according to
our results and in line with findings in a porcine model
of endotoxemia [3] as well as in liver transplant recipi-
ents [4], likely to underestimate true hepatobiliary excre-
tory dysfunction.
While it cannot be presumed that the transport of
relevant xenobiotics is affected in the same way as the
dyes used in this study, our present data may have
major implications for the understanding of drug-
induced liver injury, especially in the critically ill. Little
information is available concerning the altered pharma-
cokinetics of drugs routinely administered in the ICU;
concerns about their safety and toxicity are increasing.
For example, oral single-dose administration of atorvas-
tatin in septic patients resulted in supratherapeutic
plasma concentrations for up to 24 hours [23]. Trans-
membrane transporters are important determinants for
hepatic drug clearance that are mainly responsible for
the alterations described herein. Specifically, an impair-
ment of transporters located at the canalicular pole may
lead to intracellular accumulation of hepatotoxic com-
pounds in septic conditions potentially contributing to
drug-induced liver injury in the critical ill.
Conclusions
Taken together, our data confirm and extend the differ-
ential susceptibility of the two polar surfaces of hepato-
cytes. The liver’s capacity to transport and specifically
excrete organic anions seems to represent a particularly
vulnerable process in septic rodents and presumably in
critically ill patients with sepsis, which should be consid-
ered in ‘critical care pharmacology.’ In addition, moni-
toring of the canalicular pole might serve as an early
warning signal of hepatocellular dysfunction.
Key messages
• Hepatocellular transport is impaired in sepsis due
to an alteration of the hepatic transport machinery.
• The two polar surfaces of hepatocytes exhibit a dif-
ferential susceptibility with the canalicular pole being
more vulnerable under conditions of sepsis.
• Critical care pharmacology and diagnostics should
consider the specific impairment of canalicular
excretion since this may lead to a hepatic accumula-
tion of potentially hepatotoxic compounds.
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Additional material
Additional file 1: Visualization of hepatocellular transport by
intravital fluorescence microscopy. Sinusoidal delivery and biliary
clearance of DY635, a fluorescent dye that is primarily hepatobiliary
excreted, in a representative sham and septic animal 15 hours post
insult. After intravenous administration of the dye, images of the same
region of the liver were captured every five minutes (x40/0.6 objective
lens; the liver surface was epi-illuminated with a 100-watt mercury lamp
with two filter sets: i) 365- to 395-nm excitation and 445- to 450-nm
emission band pass filters (DAPI filterset) were applied for visualization of
the liver architecture (autofluorescence resulting from hepatocellular
reduced pyridine nucleotides (NADH)); ii) 630- to 660-nm excitation and
650- to 690-nm emission band pass filters (CY5 filterset) were applied for
visualization of DY635). In the sham animal, DY635 displayed a rapid
uptake with immediate excretion into the bile canaliculi while excretion
was impaired under conditions of sepsis.
Abbreviations
DAPI: 4’,6-diamidino-2-phenylindole; ICG: indocyanine green; IL: interleukin;
Mrp: multidrug resistance-associated protein; Mdr: multidrug resistance
protein; NADH: nicotinamide adenine dinucleotide; NIFR: near-infrared
fluorescence; Oatp: organic anion transporting polypeptide; PDR: plasma
disappearance rate; SEM: standard error of the mean.
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